IL107039A - תכשירים להשתלה תת עורית המכילים נגזרות של נומגסטרול ותהליכים לייצורם - Google Patents

תכשירים להשתלה תת עורית המכילים נגזרות של נומגסטרול ותהליכים לייצורם

Info

Publication number
IL107039A
IL107039A IL10703993A IL10703993A IL107039A IL 107039 A IL107039 A IL 107039A IL 10703993 A IL10703993 A IL 10703993A IL 10703993 A IL10703993 A IL 10703993A IL 107039 A IL107039 A IL 107039A
Authority
IL
Israel
Prior art keywords
composition according
pregna
implant
methyl
active ingredient
Prior art date
Application number
IL10703993A
Other languages
English (en)
Other versions
IL107039A0 (en
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of IL107039A0 publication Critical patent/IL107039A0/xx
Publication of IL107039A publication Critical patent/IL107039A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL10703993A 1992-09-21 1993-09-20 תכשירים להשתלה תת עורית המכילים נגזרות של נומגסטרול ותהליכים לייצורם IL107039A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9211422A FR2695826B1 (fr) 1992-09-21 1992-09-21 Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.

Publications (2)

Publication Number Publication Date
IL107039A0 IL107039A0 (en) 1993-12-28
IL107039A true IL107039A (he) 1999-01-26

Family

ID=9433868

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10703993A IL107039A (he) 1992-09-21 1993-09-20 תכשירים להשתלה תת עורית המכילים נגזרות של נומגסטרול ותהליכים לייצורם

Country Status (31)

Country Link
US (1) US5565443A (he)
EP (1) EP0613372B1 (he)
JP (1) JPH08506318A (he)
KR (1) KR100255700B1 (he)
CN (1) CN1095667C (he)
AP (1) AP497A (he)
AT (1) ATE198275T1 (he)
AU (1) AU683423B2 (he)
BG (1) BG62317B1 (he)
BR (1) BR9305642A (he)
CA (1) CA2122827A1 (he)
CZ (1) CZ284806B6 (he)
DE (1) DE69329790D1 (he)
DZ (1) DZ1717A1 (he)
EC (1) ECSP930986A (he)
FI (1) FI942272A0 (he)
FR (1) FR2695826B1 (he)
HU (1) HUT67044A (he)
IL (1) IL107039A (he)
MA (1) MA22978A1 (he)
NO (1) NO306238B1 (he)
OA (1) OA09924A (he)
PL (1) PL176120B1 (he)
RO (1) RO115783B1 (he)
RU (1) RU2120797C1 (he)
SK (1) SK54694A3 (he)
TN (1) TNSN93104A1 (he)
TW (1) TW381024B (he)
WO (1) WO1994006437A1 (he)
YU (1) YU60493A (he)
ZA (1) ZA936964B (he)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
ES2385030T3 (es) 2001-06-29 2012-07-17 Medgraft Microtech, Inc. Implantes inyectables biodegradables y procedimientos relacionados con su fabricación y uso
HUE039377T2 (hu) * 2002-05-31 2018-12-28 L Molteni & C Dei Fratelli Alitti Soc Di Esercizio S P A Beültethetõ polimer eszköz buprenorfin folytonos kibocsátására
MXPA05010450A (es) 2003-03-31 2005-11-04 Titan Pharmaceuticals Inc Dispositivo polimerico implantable para la liberacion prolongada de agonistas de dopamina.
EP1638536A2 (en) * 2003-05-30 2006-03-29 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of nalmefene
JP5619337B2 (ja) 2003-10-10 2014-11-05 フェリング ビー．ブイ． 皮膚残渣を最小限に抑えるための経皮的医薬製剤
CA2575988C (en) 2004-08-04 2014-02-18 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
CN101426475A (zh) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147783A (en) * 1974-02-28 1979-04-03 Akzona Incorporated Oral pharmaceutical preparation
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4172132A (en) * 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
FR2664895B1 (fr) * 1990-07-20 1992-10-30 Theramex Laboratoire Nouveaux derives de la 6-methyl 19-nor progesterone, substitues en 3 et leur procede d'obtention.

Also Published As

Publication number Publication date
HU9401395D0 (en) 1994-08-29
WO1994006437A1 (fr) 1994-03-31
CN1095667C (zh) 2002-12-11
PL176120B1 (pl) 1999-04-30
YU60493A (sh) 1997-01-08
JPH08506318A (ja) 1996-07-09
NO941900L (no) 1994-05-24
OA09924A (fr) 1994-09-15
IL107039A0 (en) 1993-12-28
ZA936964B (en) 1994-04-14
FR2695826A1 (fr) 1994-03-25
AU683423B2 (en) 1997-11-13
CZ284806B6 (cs) 1999-03-17
BR9305642A (pt) 1996-01-09
US5565443A (en) 1996-10-15
CA2122827A1 (fr) 1994-03-31
BG98776A (bg) 1995-02-28
HUT67044A (en) 1995-01-30
CN1094284A (zh) 1994-11-02
NO941900D0 (no) 1994-05-20
CZ116494A3 (en) 1995-03-15
BG62317B1 (bg) 1999-08-31
FI942272A (fi) 1994-05-16
EP0613372B1 (fr) 2000-12-27
NO306238B1 (no) 1999-10-11
RO115783B1 (ro) 2000-06-30
AU4822993A (en) 1994-04-12
TNSN93104A1 (fr) 1994-03-17
DZ1717A1 (fr) 2002-02-17
DE69329790D1 (de) 2001-02-01
KR100255700B1 (ko) 2000-08-01
RU2120797C1 (ru) 1998-10-27
ECSP930986A (es) 1994-04-12
ATE198275T1 (de) 2001-01-15
FI942272A0 (fi) 1994-05-16
FR2695826B1 (fr) 1995-01-06
SK54694A3 (en) 1994-10-05
MA22978A1 (fr) 1994-04-01
EP0613372A1 (fr) 1994-09-07
TW381024B (en) 2000-02-01
AP9300576A0 (he) 1993-10-31
AP497A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
US5565443A (en) Subcutaneous implants based on normegestrol derivatives
DK2905014T3 (en) An intrauterine delivery system for contraception
US4292965A (en) Intravaginal ring
EP0291838B1 (en) Oral drug delivery formulation and method for preparing same
US4346709A (en) Drug delivery devices comprising erodible polymer and erosion rate modifier
AU741482B2 (en) Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
US5733565A (en) Male contraceptive implant
JPS6059202B2 (ja) 微小な密閉された医薬放出器およびその製造方法
EA018112B1 (ru) Вагинальная система доставки
CZ110298A3 (cs) Systém pro aplikaci účinných látek
HU223690B1 (hu) Szilikonmaggal rendelkező hosszan tartóan androgént adagoló implantátum
CA2927750A1 (en) Intrauterine delivery system
Sam Controlled release contraceptive devices: a status report
EP2062569B1 (en) Vaginal delivery system
Nash et al. Nash et al.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force